Document Detail


Circulating blood volume in burn resuscitation.
MedLine Citation:
PMID:  11999459     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Circulating blood volume (CBV) was prospectively measured in patients with almost solely smoke inhalation injury (Group I: 10 patients) and in patients with severe cutaneous burn (Group B: 6 patients) consecutively until 96 hours after injury, to assess the effect of either injury on intravascular volume status by the pulse dye-densitometry method. All participants were treated by an ordinary fluid regimen based on the Parkland formula with an hourly urine output of 1.0 to 2.0 ml/kg for the resuscitation endpoint. CBV was also measured in 15 elective surgical patients for a control value (76.7+/-9.0 ml/kg). The level of CBV values in Group I was low, ranging from 54.4+/-6.9 ml/kg to 59.6+/-6.2 ml/kg (from 70.9% to 77.7% of control value), while in Group B from 48.5+/-5.5 ml/kg to 55.6+/-17.3 ml/kg (from 63.2% to 72.5%) until 72 hours after injury. There was no significant difference in CBV values between the two groups throughout the study period. We could elucidate the existence and extent of intravascular volume depletion in spite of optimal fluid treatment in both solely smoke inhalation injury and solely severe cutaneous burn. Almost solely inhalation injury was found to decrease CBV to less than that of severe cutaneous burn, which presumably led to the increased fluid requirement. Concerning the resuscitation endpoint in early burn treatment, this depletion in CBV must be taken in mind. Hourly urine output is speculated to be an effective and practical clue to manage a burn patient within permissive hypovolemia.
Authors:
Takeshi Inoue; Kiyoshi Okabayashi; Minako Ohtani; Takao Yamanoue; Seishi Wada; Koji Iida
Related Documents :
10163609 - Comparison of inhaled metaproterenol via metered-dose and hand-held nebulization in pre...
12911119 - Improved control of asthma symptoms with a reduced dose of hfa-bdp extrafine aerosol: a...
6408619 - Efficacy of inhaled tobramycin in the treatment of pulmonary exacerbations in children ...
16923699 - Nebulized pentoxifylline for prevention of bronchopulmonary dysplasia in very low birth...
10999799 - Stimulatory effect of adrenocorticotropin on cortisol, aldosterone, and dehydroepiandro...
23360419 - Pharmacodynamic and pharmacokinetic evaluation of coadministration of lacosamide and an...
10718389 - Improved sedation in diagnostic and therapeutic ercp: propofol is an alternative to mid...
7188579 - Optimal dosages of methylphenidate for improving the learning and behavior of hyperacti...
17294999 - A comparison of the efficacies of different pre-treatment drugs in resolving the inject...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Hiroshima journal of medical sciences     Volume:  51     ISSN:  0018-2052     ISO Abbreviation:  Hiroshima J. Med. Sci.     Publication Date:  2002 Mar 
Date Detail:
Created Date:  2002-05-09     Completed Date:  2002-10-11     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0421060     Medline TA:  Hiroshima J Med Sci     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  7-13     Citation Subset:  IM    
Affiliation:
Department of Emergency and Critical Care Medicine, Hiroshima University School of Medicine, Japan. tinoue@hiroshima-u.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Aged, 80 and over
Blood Volume*
Burns / blood*,  therapy
Female
Humans
Lactic Acid / blood
Male
Middle Aged
Resuscitation*
Chemical
Reg. No./Substance:
50-21-5/Lactic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of nicotine chewing gum on UPDRS score and P300 in early-onset parkinsonism.
Next Document:  Molecular aspects of bladder cancer III. Prognostic markers of bladder cancer.